Drug approvals - Page 51 of 66 - Express Pharma

Xentria gets US FDA orphan drug designation for XTMAB-16 in sarcoidosis

US FDA nod for Ocrevus (ocrelizumab) shorter 2-hour infusion for relapsing and primary progressive MS

Biocon Biologics, Mylan get CHMP recommendation for approval of biosimilar insulin Aspart

Alembic Pharma gets USFDA final approval for Asenapine Sublingual Tablets

Biogen applies for approval of Alzheimer’s drug, aducanumab in Japan

USFDA grants Zydus fast track designation for Saroglitazar to treat primary biliary cholangitis

Aurobindo gets USFDA nod for dexmedetomidine HCL in 0.9% sodium chloride injection

Granules India gets US FDA approval for Penicillamine Capsules

Alembic Pharma gets final nod form US FDA for Metolazone Tablets

Genentech gets US FDA nod for Gavreto to treat RET-mutant, RET fusion-positive thyroid cancers